While most people welcome the end of winter, the coming of spring poses problems if you suffer with seasonal allergic rhinitis. You can turn to decongestants and antihistamines, but a better approach is to treat underlying causes by avoiding allergens—a challenge during springtime—and modulating your overactive immune response.
In a recent study, volunteers with allergic rhinitis took 500 mg of EpiCor, a Saccharomyces cerevisiae (baker’s yeast) extract, or a placebo for 12 weeks during peak pollen season. Compared to the placebo group, those who took EpiCor had significant reductions in nasal congestion and discharge and experienced 12.5 fewer days of suffering with a stuffy nose. In addition, their levels of protective antibodies in the nasal mucous membranes increased.
Although EpiCor has been best studied for its ability to stave off colds and flu, its immune-modulating properties provide multiple benefits. The recommended dose is 500 mg per day.